+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 44Years
FEMALE
ID06889831

Digital Group Program to Help Women in the Criminal Justice System Reduce Drug Use and Improve Contraceptive Use For Women Aged 18 to 44 with Substance Use Disorders

Led by Fairleigh Dickinson University · Updated on 2026-05-06

50

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Women involved in the criminal legal system often face higher rates of substance use disorders and unintended pregnancy compared to the general population, along with barriers to accessing treatment and reproductive health services. This research evaluates the WORTH Paths digital intervention, adapted from an evidence-based CDC HIV prevention program, aimed at helping reproductive-aged women in this group reduce drug use and improve contraceptive use. The study is a randomized controlled trial comparing this intervention to a general wellness program without skills-based training. Participants will be randomly assigned to either the WORTH Paths Intervention Group or the Control Group. The intervention group will participate in three virtual group sessions with facilitators via videoconference, combined with self-paced digital activities that focus on reducing substance use and increasing contraceptive use. This includes education on various contraceptive methods, skill-building exercises, motivational interviewing, safety planning, and guidance on accessing health services. The control group will receive three virtual sessions focused on general wellness, stress reduction, and health education without behavioral skill training. Both groups will receive resources and referrals for substance use treatment and reproductive health care. Participants will be involved for at least three months, completing surveys and mail-in urine drug tests at enrollment and follow-up to measure drug use changes. Researchers will monitor attendance, treatment completion, dropout rates, and participant satisfaction to assess feasibility and acceptability. Primary outcomes include self-reported and biologically confirmed changes in drug use and contraceptive use. Secondary outcomes track linkage to substance use treatment. Safety and privacy measures are in place, and participants may withdraw at any time.

CONDITIONS

Brief Title

WORTH Paths Intervention

Research Team

M

Melissa N Slavin, PhD

A

Annie J Rohan, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here